The results showed that the upregulation of PANDAR expression predicts poor prognosis of GC by meta-analysis (HR = 3.11, 95% CI = 2.72–3.55), hence PANDAR is a powerful candidate gene for predicting the prognosis of GC patients [16]. The gene discussed is PANDAR; the disease is gastric cancer.